Biovie (BIVI) Current Assets (2013 - 2026)
Biovie (BIVI) posted Current Assets of $16.9 million for Q1 2026, down 22.54% sequentially from $21.8 million in Q4 2025, and down 28.84% YoY from $23.7 million in Q1 2025.
Biovie (BIVI) Current Assets (2013 - 2026) Analysis & Trends
Biovie has reported Current Assets for 14 years, with the latest figure at $16.9 million in Q1 2026.
- Quarterly Current Assets fell 28.84% year-over-year to $16.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.9 million (down 28.84% YoY) and the FY2025 annual result came in at $20.7 million, down 13.93% from the prior year.
- Current Assets retreated to $16.9 million in Q1 2026 per BIVI's latest filing, from $21.8 million in the prior quarter.
- Over five years, Current Assets peaked at $46.0 million in Q4 2022 and troughed at $16.9 million in Q1 2026.
- A 5-year average of $25.9 million and a median of $23.7 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2023: Current Assets surged 307.8% in 2022, then plunged 55.29% in 2023.
- Over 5 years, Current Assets stood at $46.0 million in 2022, then sank by 55.29% to $20.6 million in 2023, then gained by 20.04% to $24.7 million in 2024, then decreased by 11.71% to $21.8 million in 2025, then fell by 22.54% to $16.9 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $16.9 million, $21.8 million, and $26.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 1.76 Bn |
| 10 | Biovie | 13.56 Mn | 13.56 Mn | - | 13.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.64 Mn |
| Mar 31, 2026 | 16.88 Mn |
| Dec 31, 2025 | 21.79 Mn |
| Sep 30, 2025 | 26.03 Mn |
| Jun 30, 2025 | 20.70 Mn |
| Mar 31, 2025 | 23.72 Mn |
| Dec 31, 2024 | 24.68 Mn |
| Sep 30, 2024 | 20.15 Mn |
| Jun 30, 2024 | 24.05 Mn |
| Mar 31, 2024 | 30.54 Mn |
| Dec 31, 2023 | 20.56 Mn |
| Sep 30, 2023 | 22.76 Mn |
| Jun 30, 2023 | 34.04 Mn |
| Mar 31, 2023 | 44.05 Mn |
| Dec 31, 2022 | 45.99 Mn |
| Sep 30, 2022 | 21.59 Mn |
| Jun 30, 2022 | 18.78 Mn |
| Mar 31, 2022 | 24.79 Mn |
| Dec 31, 2021 | 30.55 Mn |
| Sep 30, 2021 | 20.59 Mn |